归创通桥医疗科技股份有限公司（股票代码：02190）于2026年3月27日公告，董事会批准并实施了股份回购措施。公司在香港联交所场内回购H股共150,000股，占当日已发行股本约0.0445%。回购价格介乎每股23.66港元至24.10港元，合计支付约3,587,840港元（约358.78万港元）。
本次回购完成后，公司已发行股本变动为328,896,113股，库藏股数增至7,454,631股。回购授权由公司于2025年5月30日获批，授权总数为31,958,111股。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。
本公告由公司董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.